|
|
regulation of interleukin 1 mediated signaling pathway
|
GO:2000659 |
3 |
1.000
|
|
|
|
negative regulation of interleukin 1 mediated signaling pathway
|
GO:2000660 |
2 |
0.999
|
|
|
|
negative regulation of jun kinase activity
|
GO:0043508 |
4 |
0.981
|
|
|
|
negative regulation of tumor necrosis factor mediated signaling pathway
|
GO:0010804 |
7 |
0.930
|
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.920
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
18 |
0.912
|
|
|
|
interleukin 1 mediated signaling pathway
|
GO:0070498 |
12 |
0.892
|
|
|
|
cellular response to interleukin 1
|
GO:0071347 |
35 |
0.885
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.846
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.818
|
|
|
|
regulation of tumor necrosis factor mediated signaling pathway
|
GO:0010803 |
12 |
0.813
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.812
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
16 |
0.782
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
27 |
0.761
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.729
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.726
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.724
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.723
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.721
|
|
|
|
response to interleukin 1
|
GO:0070555 |
47 |
0.717
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
21 |
0.713
|
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.666
|
|
|
|
regulation of transcription regulatory region dna binding
|
GO:2000677 |
15 |
0.660
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.660
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.659
|
|
|
|
negative regulation of jnk cascade
|
GO:0046329 |
16 |
0.651
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.644
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.610
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.609
|
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
25 |
0.598
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.575
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.571
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.566
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
24 |
0.558
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.542
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.537
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.535
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.505
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.503
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.496
|
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.494
|
Human |
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.487
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.485
|
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.444
|
Human |
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.438
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.438
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.437
|
|
|
|
negative regulation of stress activated mapk cascade
|
GO:0032873 |
19 |
0.417
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.401
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.371
|
|
|
|
limb morphogenesis
|
GO:0035108 |
16 |
0.366
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.356
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.356
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.339
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.317
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.303
|
|
|
|
appendage development
|
GO:0048736 |
23 |
0.299
|
Human |
|
|
appendage morphogenesis
|
GO:0035107 |
16 |
0.293
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.287
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.285
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.285
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.282
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.266
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.266
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.248
|
|
|
|
negative regulation of osteoclast differentiation
|
GO:0045671 |
8 |
0.247
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.240
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.236
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.233
|
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.224
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.222
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.220
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.208
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.205
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.203
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.185
|
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.182
|
Human |
|
|
negative regulation of stress activated protein kinase signaling cascade
|
GO:0070303 |
19 |
0.168
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.163
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.159
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
46 |
0.152
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.141
|
Human |
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.138
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.134
|
|
|
|
limb development
|
GO:0060173 |
23 |
0.132
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.116
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
27 |
0.115
|
|
|
|
negative regulation of transcription regulatory region dna binding
|
GO:2000678 |
6 |
0.089
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.088
|
Human |
|
|
negative regulation of dna binding
|
GO:0043392 |
18 |
0.072
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
27 |
0.064
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.062
|
|
|
|
head development
|
GO:0060322 |
108 |
0.055
|
Human |
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.052
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.048
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.046
|
Human |
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.046
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.044
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.042
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.042
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.041
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.039
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.039
|
|
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
4 |
0.038
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.038
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.037
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.037
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.036
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.035
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.034
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.031
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.029
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.029
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.029
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.028
|
|
|
|
immunoglobulin secretion
|
GO:0048305 |
1 |
0.028
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.027
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.027
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.026
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.026
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.026
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.026
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.026
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.025
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.025
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.024
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.024
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.024
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.023
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.023
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.023
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.023
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.023
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.022
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.022
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.022
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.022
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.022
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.022
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.022
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.021
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.021
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.020
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.020
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.020
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.019
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.019
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.019
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.019
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.018
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.018
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
4 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.017
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.017
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.017
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.017
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.017
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.017
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.017
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.017
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.017
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.016
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.016
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.016
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.016
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.016
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.016
|
|
|
|
translation
|
GO:0006412 |
132 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.016
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
4 |
0.016
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.016
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.016
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.016
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.016
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.015
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.015
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.015
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.015
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.015
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.015
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.015
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.015
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.015
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.015
|
|
|
|
defense response to fungus
|
GO:0050832 |
4 |
0.015
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.015
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.015
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.014
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.014
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.014
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.014
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.014
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.014
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.014
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.014
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.014
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.013
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.013
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.013
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.013
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.013
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.013
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.013
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.013
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.013
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.013
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.013
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.013
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.013
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.013
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.013
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.012
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.012
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.012
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.012
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.012
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.012
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.012
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.012
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.012
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.012
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.012
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.012
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.012
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.012
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.012
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.012
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.012
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.012
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.012
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.012
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.012
|
|
|
|
system process
|
GO:0003008 |
349 |
0.011
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.011
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.011
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
3 |
0.011
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.011
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.011
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.011
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.011
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.011
|
|
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.011
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.011
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.011
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.011
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.011
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.011
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.011
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.011
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.011
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.011
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.011
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.011
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.011
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.011
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.011
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.011
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.011
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.011
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.011
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.011
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.011
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.011
|
|
|
|
mating
|
GO:0007618 |
1 |
0.011
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.011
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.010
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.010
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.010
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.010
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.010
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.010
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.010
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.010
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.010
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.010
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.010
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.010
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
2 |
0.010
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.010
|
|
|
|
positive regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035360 |
4 |
0.010
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.010
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.010
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.010
|
|